Your browser doesn't support javascript.
loading
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.
Treis, Diana; Umapathy, Ganesh; Fransson, Susanne; Guan, Jikui; Mendoza-García, Patricia; Siaw, Joachim T; Wessman, Sandra; Gordon Murkes, Lena; Stenman, Jakob J E; Djos, Anna; Elfman, Lotta H M; Johnsen, John Inge; Hallberg, Bengt; Palmer, Ruth H; Martinsson, Tommy; Kogner, Per.
Afiliación
  • Treis D; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Pediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Umapathy G; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Fransson S; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Guan J; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Mendoza-García P; Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
  • Siaw JT; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Wessman S; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Gordon Murkes L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Stenman JJE; Department of Clinical Pathology, Karolinska University Hospital, Stockholm, Sweden.
  • Djos A; Department of Pediatric Radiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Elfman LHM; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Pediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Johnsen JI; Department of Pediatric Surgery, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Hallberg B; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Palmer RH; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Pediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Martinsson T; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Pediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Kogner P; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
JCO Precis Oncol ; 6: e2100271, 2022 01.
Article en En | MEDLINE | ID: mdl-35085006
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzamidas / Inhibidores de Proteínas Quinasas / Indazoles / Neuroblastoma Límite: Humans / Infant / Male Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzamidas / Inhibidores de Proteínas Quinasas / Indazoles / Neuroblastoma Límite: Humans / Infant / Male Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Suecia